CAS 25541-09-7

lacto-N-fucopentaose iii*from human milk

Description:

Lacto-N-fucopentaose III (LNFP III) is a complex oligosaccharide predominantly found in human milk. It is classified as a fucosylated human milk oligosaccharide (HMO) and plays a significant role in infant nutrition and development. LNFP III is composed of a core lactose structure with additional fucose and N-acetylglucosamine residues, contributing to its unique properties. This oligosaccharide is known for its prebiotic effects, promoting the growth of beneficial gut bacteria, which can enhance the infant's immune system and overall gut health. Additionally, LNFP III has been shown to inhibit the adhesion of pathogens to the intestinal epithelium, thereby providing a protective effect against infections. Its presence in human milk varies among individuals and can be influenced by maternal genetics and dietary factors. The CAS number 25541-09-7 specifically identifies this compound, facilitating its study in various scientific and nutritional research contexts. Overall, LNFP III exemplifies the complexity and functional importance of HMOs in human lactation.

Formula: C₃₂H₅₅NO₂₅

InChI: InChI=1/C32H55NO25/c1-8-16(42)20(46)22(48)30(51-8)57-27-15(33-9(2)39)29(54-14(7-38)26(27)56-31-23(49)21(47)18(44)12(5-36)52-31)58-28-19(45)13(6-37)53-32(24(28)50)55-25(11(41)4-35)17(43)10(40)3-34/h3,8,10-32,35-38,40-50H,4-7H2,1-2H3,(H,33,39)

InChI key: InChIKey=WMYQZGAEYLPOSX-QKPOUJQKSA-N

SMILES: O([C@H]1[C@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](O[C@@H]([C@@H]([C@H](C=O)O)O)[C@@H](CO)O)O[C@H](CO)[C@@H]3O)[C@@H]1NC(C)=O)[C@H]4[C@@H](O)[C@H](O)[C@H](O)[C@H](C)O4

Synonyms:

• 6-Deoxyhexopyranosyl-(1->3)-[Hexopyranosyl-(1->4)]-2-(Acetylamino)-2-Deoxyhexopyranosyl-(1->3)Hexopyranosyl-(1->4)Hexose
• <span class="text-smallcaps">D</smallcap>-Glucose, O-6-deoxy-α-<smallcap>L</smallcap>-galactopyranosyl-(1→3)-O-[β-<smallcap>D</smallcap>-galactopyranosyl-(1→4)]-O-2-(acetylamino)-2-deoxy-β-<smallcap>D</smallcap>-glucopyranosyl-(1→3)-O-β-<smallcap>D</span>-galactopyranosyl-(1→4)-
• Glucopyranose, O-6-deoxy-α-<span class="text-smallcaps">L</smallcap>-galactopyranosyl-(1→3)-O-[β-<smallcap>D</smallcap>-galactopyranosyl-(1→4)]-O-2-acetamido-2-deoxy-β-<smallcap>D</smallcap>-glucopyranosyl-(1→3)-O-β-<smallcap>D</smallcap>-galactopyranosyl-(1→4)-, <smallcap>D</span>-
• Lacto-N-fucopentaose III
• Lacto-N-fucopentaose III, Human Milk
• Lacto-N-fucopentoase-3
• Lacto-N-neofucopentaose II
• Le^x penta
• Lnf Iii
• Lnfp Iii
• O-6-Deoxy-α-<span class="text-smallcaps">L</smallcap>-galactopyranosyl-(1→3)-O-[β-<smallcap>D</smallcap>-galactopyranosyl-(1→4)]-O-2-(acetylamino)-2-deoxy-β-<smallcap>D</smallcap>-glucopyranosyl-(1→3)-O-β-<smallcap>D</smallcap>-galactopyranosyl-(1→4)-<smallcap>D</span>-glucose
• Glucopyranose, O-6-deoxy-α-L-galactopyranosyl-(1→3)-O-[β-D-galactopyranosyl-(1→4)]-O-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-, D-
• O-6-Deoxy-α-L-galactopyranosyl-(1→3)-O-[β-D-galactopyranosyl-(1→4)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-D-glucose
• D-Glucose, O-6-deoxy-α-L-galactopyranosyl-(1→3)-O-[β-D-galactopyranosyl-(1→4)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-
• LACTO-N-FUCOPENTAOSE III-GEL
• BETA-D-GAL-[1->4]-(ALPHA-L-FUC-[1->3])-BETA-D-GLCNAC-[1->3]-BETA-D-GAL-[1->4]-D-GLC
• III3FUC-NLCOSE4
• LNF III-GEL
• LEWIS-X-PENTASACCHARIDE-GEL
• GAL-BETA1,4(FUC-ALPHA1,3)GLCNAC-BETA1,3GAL-BETA1,4GLC
• β-d-gal-(1→4)-[α-l-fuc-(1→3)]-β-d-glcnac-(1→3)-β-d-gal-(1→4)-d-glc
• CD15 ANTIGEN
• N-[2-[3,5-dihydroxy-2-(hydroxymethyl)-6-(1,2,4,5-tetrahydroxy-6-oxohexan-3-yl)oxyoxan-4-yl]oxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-3-yl]acetamide
• Lacto-N-fucopentaose III ,95%
• LEX-PENTASACCHARIDE
• LEWIS-X PENTASACCHARIDE
• LEX
• Lex-lactose, Lewis-X pentasaccharide, LNFP III, β-D-Gal-(1-4)-[α-L-Fuc-(1-3)]-β-D-GlcNAc-(1-3)-β-D-Gal-(1-4)-D-Glc
• LE(X)-LACTOSE

O-6-Deoxy-α-L-galactopyranosyl-(1→3)-O-[β-D-galactopyranosyl-(1→4)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-D-glucose

CAS: 25541-09-7

Formula: C₃₂H₅₅NO₂₅

Purity: ≥95%

Color and Shape: Solid

Molecular weight: 853.7708

Ref: IN-DA007MS9

Lacto-N-fucopentaose III

CAS: 25541-09-7

Formula: C₃₂H₅₅NO₂₅

Purity: ≥ 95%

Color and Shape: White to almost white lyophilised powder

Molecular weight: 853.77

Ref: 7W-GC2450

Lacto-N-fucopentaose III

CAS: 25541-09-7

Neutral pentasaccharide naturally present in human breast milk

Formula: C₃₂H₅₅NO₂₅

Purity: Min. 95%

Color and Shape: White Powder

Molecular weight: 853.77 g/mol

Ref: 3D-OL04212

Lacto-N-fucopentaose III-GEL

CAS: 25541-09-7

Lacto-N-fucopentaose III-GEL is a synthetic monosaccharide that is used as a building block for the synthesis of complex carbohydrates. Lacto-N-fucopentaose III-GEL is synthesized from fructose, which is methylated with chloromethylated N,N'-diacetylchitobiose as the methylating agent and sodium methoxide as the catalyst. The resulting glycoconjugate is then treated with hydrofluoric acid to introduce fluorine atoms into the carbohydrate backbone.

Purity: Min. 95%

Ref: 3D-OL05682